European VCs Form Coalition to Bridge Life Sciences Funding Gap
Leading European venture capital firms have launched the European Life Sciences Coalition to address a systemic funding crisis and prevent the migration of high-growth biotech firms to U.S. markets. The initiative seeks to unlock institutional capital and harmonize regulations to bridge the late-stage investment gap between Europe and North America.